Theriva Biologics Inc. (TOVX) — Net Asset Quality Index
Theriva Biologics Inc. (TOVX) has a Net Asset Quality Index of 40.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $38.25 Million minus total liabilities of $22.85 Million yields net assets of $15.40 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Theriva Biologics Inc. (TOVX) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Theriva Biologics Inc. Net Asset Quality Index Over Time (1993–2025)
This chart shows how Theriva Biologics Inc.'s Net Asset Quality Index has evolved across 31 annual periods from 1993 to 2025. As of March 2026, the index stands at 40.3%, representing net assets of $15.40 Million against total assets of $38.25 Million USD. See TOVX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Theriva Biologics Inc. (1993–2025)
The table below presents the year-by-year Net Asset Quality Index for Theriva Biologics Inc. from 1993 to 2025, covering 31 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Theriva Biologics Inc. (TOVX) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 40.2% | $15.38 Million | $38.24 Million | $22.86 Million | ▼ -13.7 pp |
| 2024 | 53.9% | $19.07 Million | $35.35 Million | $16.29 Million | ▼ -18.0 pp |
| 2023 | 71.9% | $39.70 Million | $55.22 Million | $15.52 Million | ▼ -4.0 pp |
| 2022 | 75.9% | $54.56 Million | $71.86 Million | $17.30 Million | ▼ -17.0 pp |
| 2021 | 93.0% | $65.41 Million | $70.36 Million | $4.96 Million | ▲ +30.4 pp |
| 2020 | 62.5% | $5.26 Million | $8.41 Million | $3.15 Million | ▼ -4.1 pp |
| 2019 | 66.6% | $11.49 Million | $17.23 Million | $5.75 Million | ▼ -21.1 pp |
| 2018 | 87.8% | $26.45 Million | $30.14 Million | $3.69 Million | ▲ +105.9 pp |
| 2017 | -18.1% | $-3.41 Million | $18.84 Million | $22.25 Million | ▼ -28.1 pp |
| 2016 | 10.0% | $2.25 Million | $22.50 Million | $20.25 Million | ▼ -38.6 pp |
| 2015 | 48.6% | $15.00 Million | $30.84 Million | $15.84 Million | ▼ -1.3 pp |
| 2014 | 49.9% | $9.56 Million | $19.14 Million | $9.59 Million | ▼ -43.8 pp |
| 2013 | 93.7% | $15.23 Million | $16.26 Million | $1.03 Million | ▼ -3.4 pp |
| 2012 | 97.1% | $13.03 Million | $13.42 Million | $395.00K | ▲ +2.6 pp |
| 2011 | 94.4% | $7.06 Million | $7.48 Million | $417.00K | ▲ +7.4 pp |
| 2010 | 87.0% | $3.58 Million | $4.11 Million | $532.48K | ▲ +0.1 pp |
| 2009 | 87.0% | $3.54 Million | $4.08 Million | $531.43K | ▼ -4.6 pp |
| 2008 | 91.6% | $6.76 Million | $7.39 Million | $620.72K | ▲ +4.0 pp |
| 2007 | 87.6% | $11.95 Million | $13.63 Million | $1.69 Million | ▼ -6.6 pp |
| 2006 | 94.2% | $11.79 Million | $12.52 Million | $729.02K | ▲ +143.1 pp |
| 2005 | -48.9% | $-703.84K | $1.44 Million | $2.14 Million | ▲ +966.9 pp |
| 2002 | -1015.8% | $-15.39 Million | $1.51 Million | $16.90 Million | ▼ -573.9 pp |
| 2001 | -441.9% | $-9.09 Million | $2.06 Million | $11.14 Million | ▼ -434.3 pp |
| 2000 | -7.6% | $-413.72K | $5.45 Million | $5.86 Million | ▼ -20.9 pp |
| 1999 | 13.3% | $671.07K | $5.05 Million | $4.38 Million | ▼ -10.8 pp |
| 1998 | 24.1% | $700.00K | $2.90 Million | $2.20 Million | ▲ +338.4 pp |
| 1997 | -314.3% | $-2.20 Million | $700.00K | $2.90 Million | ▼ -375.0 pp |
| 1996 | 60.7% | $1.70 Million | $2.80 Million | $1.10 Million | ▼ -21.1 pp |
| 1995 | 81.8% | $1.80 Million | $2.20 Million | $400.00K | ▲ +206.8 pp |
| 1994 | -125.0% | $-500.00K | $400.00K | $900.00K | ▼ -213.9 pp |
| 1993 | 88.9% | $1.60 Million | $1.80 Million | $200.00K | — |